Friday, August 1, 2025

1:15 PM - 2:15 PM

Pyrmont Theatre

---

Details

Cardiovascular disease remains a leading cause of mortality in Australia, accounting for 24% of deaths in 2022 (AIHW). Conditions like pulmonary embolism (PE), angina, transient ischaemic attack (TIA), and pericarditis present critical challenges in diagnosis and management. This masterclass will give pharmacists a deep dive into recognising, assessing, and supporting patients with these conditions. Through case-based discussions, expert insights, and the latest clinical updates, attendees will strengthen their knowledge of CVD presentations, risk stratification, and pharmacist interventions to optimise patient outcomes. Learning objectives - Discuss the burden of cardiovascular disease and its impact on patient outcomes. - Recognise common presentations and risk factors of acute cardiovascular events. - Describe the pharmacist’s role in early detection and management of cardiovascular conditions. - Identify evidence-based approaches to optimise CVD care in pharmacy practice. Competency Standards (2016) 1.6, 3.1, 3.3, 3.5